The Marked Chart Wire · Markets
HotMarket Movers
Inovio surges on FDA approval, Oracle falls on AI debt plans
Inovio shares jumped 242 percent after the FDA approved its first DNA-based immunotherapy. Oracle dropped 6.7 percent as it announced plans to raise $20 billion to fund AI infrastructure.
